[1] Göbel T, Graf D, Hosnowsky C, et al. Multimodal and sequential treatment improves survival in patients with hepatocellular carcinoma[J]. Z Gastroenterol,2017,55(3): 251-259.
[2] Gao XM, Zhang R, Dong QZ, Qin LX. Properties and feasibility of using cancer stem cells in clinical cancer treatment[J]. Cancer Biol Med,2016,13(4): 489-495.
[3] Ren KQ, Cao XZ, Liu ZH, et al. 8-bromo-5-hydroxy-7-methoxychrysin targeting for inhibition of the properties of liver cancer stem cells by modulation of Twist signaling[J]. Int J Oncol,2013,43(5): 1719-29.
[4] Quan MF, Xiao LH, Liu ZH, et al. 8-bromo-7-methoxychrysin inhibits properties of liver cancer stem cells via downregulation of β-catenin[J]. World J Gastroenterol, 2013,19(43): 7680-95.
[5] Sun S, Cui Y, Ren K, et al. 8-bromo-7-methoxychrysin Reversed M2 Polarization of Tumor-associated Macrophages Induced by Liver Cancer Stem-like Cells[J]. Anticancer Agents Med Chem,2017, 17(2): 286-293.
[6] Cao X, Zou H, Cao J, et al. A candidate Chinese medicine preparation-Fructus Viticis Total Flavonoids inhibits stem-like characteristics of lung cancer stem-like cells[J]. BMC Complement Altern Med,2016,16: 364.
[7] Mancini M, Castagnetti F, Soverini S, et al. FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage[J]. J Cell Biochem, 2017 .
[8] Dai B, Kang SH, Gong W, et al. Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells[J]. Oncogene, 2007, 26(42): 6212-9.
[9] Chen PM, Wu TC, Shieh SH, et al. MnSOD promotes tumor invasion via upregulation of FoxM1-MMP2 axis and related with poor survival and relapse in lung adenocarcinomas[J]. Mol Cancer Res, 2013. 11(3): 261-71.
基金
国家自然科学基金面上项目(No.81172375);湖南省教育厅重点资助项目(11A073);湖南省科技厅科研基金资助项目(2012SK3126)